ABC disease affects millions world-wide. The World Health Organization (WHO) reports that the incidence of this common but dangerous disease has increased over 60% since 2000.
This research study is testing the effectiveness of an investigational medication at reducing the symptoms of ABC.
Qualified participants in this study must be:
- at least 18 years of age
- diagnosed with ABC for at least 6-months
- Qualified participants will be seen by a doctor and receive all study related care, tests and medications at no cost. Compensation for time and travel may be available.
Qualified participants will be seen by a doctor and receive all study related care, tests and medications at no cost. Compensation for time and travel may be available.